APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyclophosphamide

Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.

Selected research

Industry Growth & Trends

Global Cyclophosphamide Industry Growth and Trends Forecast to 2032

26 December 202597 pages

Choose your research edition.

Industry ResearchCyclophosphamide Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyclophosphamide Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Cyclophosphamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyclophosphamide Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyclophosphamide Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.

Top 8 manufacturers took 75.4% market share in 2019.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Cyclophosphamide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cyclophosphamide market size, estimates, and forecasts are presented in terms of sales volume (Person) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cyclophosphamide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cyclophosphamide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cyclophosphamide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cyclophosphamide Market by Company

Baxter

Novartis

Hikma Pharmaceuticals

Amneal Pharmaceuticals LLC

Jiangsu Hengrui Medicine

NorthStar Rx LLC

GLS Pharma

CSC Pharmaceuticals International

Cyclophosphamide Segment by Type

High-Dose

Low-Dose

Cyclophosphamide Segment by Application

Cancer

Autoimmune Diseases

AL Amyloidosis

Others

Cyclophosphamide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclophosphamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyclophosphamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclophosphamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cyclophosphamide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cyclophosphamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of High-Dose Table 2. Major Company of Low-Dose Table 3. Global Cyclophosphamide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cyclophosphamide Sales by Type (2021-2026) & (Person) Table 5. Global Cyclophosphamide Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cyclophosphamide Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cyclophosphamide Sales Market Share in Value by Type (2021-2026) Table 8. Global Cyclophosphamide Price by Type (2021-2026) & (USD/Person) Table 9. Global Cyclophosphamide Sales by Type (2027-2032) & (Person) Table 10. Global Cyclophosphamide Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cyclophosphamide Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cyclophosphamide Sales Market Share in Value by Type (2027-2032) Table 13. Global Cyclophosphamide Price by Type (2027-2032) & (USD/Person) Table 14. North America Cyclophosphamide Sales by Type (2021-2026) & (Person) Table 15. North America Cyclophosphamide Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cyclophosphamide Sales by Type (2021-2026) & (Person) Table 17. Europe Cyclophosphamide Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cyclophosphamide Sales by Type (2021-2026) & (Person) Table 19. Asia-Pacific Cyclophosphamide Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cyclophosphamide Sales by Type (2021-2026) & (Person) Table 21. Latin America Cyclophosphamide Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cyclophosphamide Sales by Type (2021-2026) & (Person) Table 23. Middle East and Africa Cyclophosphamide Sales by Type (2021-2026) & (US$ Million) Table 24. Cyclophosphamide Industry Trends Table 25. Cyclophosphamide Industry Drivers Table 26. Cyclophosphamide Industry Opportunities and Challenges Table 27. Cyclophosphamide Industry Restraints Table 28. Global Cyclophosphamide Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cyclophosphamide Revenue Market Share by Company (2021-2026) Table 30. Global Cyclophosphamide Sales by Company (2021-2026) & (Person) Table 31. Global Cyclophosphamide Sales Share by Company (2021-2026) Table 32. Global Cyclophosphamide Market Price by Company (2021-2026) & (USD/Person) Table 33. Global Cyclophosphamide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cyclophosphamide Major Company Production Sites and Headquarters Table 35. Global Cyclophosphamide Company, Product Type & Application Table 36. Global Cyclophosphamide Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cyclophosphamide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cyclophosphamide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cyclophosphamide Sales by Region (2021-2026) & (Person) Table 41. Global Cyclophosphamide Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cyclophosphamide Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cyclophosphamide Sales Market Share in Value by Region (2021-2026) Table 44. Global Cyclophosphamide Sales (Person), Value (US$ Million), Price (USD/Person) and Gross Margin (2021-2026) Table 45. Global Cyclophosphamide Sales by Region (2027-2032) & (Person) Table 46. Global Cyclophosphamide Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cyclophosphamide Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cyclophosphamide Sales Market Share in Value by Region (2027-2032) Table 49. Global Cyclophosphamide Sales (Person), Value (US$ Million), Price (USD/Person) and Gross Margin (2027-2032) Table 50. Global Cyclophosphamide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cyclophosphamide Sales by Application (2021-2026) & (Person) Table 52. Global Cyclophosphamide Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cyclophosphamide Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cyclophosphamide Sales Market Share in Value by Application (2021-2026) Table 55. Global Cyclophosphamide Price by Application (2021-2026) & (USD/Person) Table 56. Global Cyclophosphamide Sales by Application (2027-2032) & (Person) Table 57. Global Cyclophosphamide Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cyclophosphamide Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cyclophosphamide Sales Market Share in Value by Application (2027-2032) Table 60. Global Cyclophosphamide Price by Application (2027-2032) & (USD/Person) Table 61. North America Cyclophosphamide Sales by Application (2021-2026) & (Person) Table 62. North America Cyclophosphamide Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cyclophosphamide Sales by Application (2021-2026) & (Person) Table 64. Europe Cyclophosphamide Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cyclophosphamide Sales by Application (2021-2026) & (Person) Table 66. Asia-Pacific Cyclophosphamide Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cyclophosphamide Sales by Application (2021-2026) & (Person) Table 68. Latin America Cyclophosphamide Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cyclophosphamide Sales by Application (2021-2026) & (Person) Table 70. Middle East and Africa Cyclophosphamide Sales by Application (2021-2026) & (US$ Million) Table 71. Baxter Company Information Table 72. Baxter Business Overview Table 73. Baxter Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (USD/Person) and Gross Margin (2021-2026) Table 74. Baxter Cyclophosphamide Product Portfolio Table 75. Baxter Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (USD/Person) and Gross Margin (2021-2026) Table 79. Novartis Cyclophosphamide Product Portfolio Table 80. Novartis Recent Development Table 81. Hikma Pharmaceuticals Company Information Table 82. Hikma Pharmaceuticals Business Overview Table 83. Hikma Pharmaceuticals Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (USD/Person) and Gross Margin (2021-2026) Table 84. Hikma Pharmaceuticals Cyclophosphamide Product Portfolio Table 85. Hikma Pharmaceuticals Recent Development Table 86. Amneal Pharmaceuticals LLC Company Information Table 87. Amneal Pharmaceuticals LLC Business Overview Table 88. Amneal Pharmaceuticals LLC Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (USD/Person) and Gross Margin (2021-2026) Table 89. Amneal Pharmaceuticals LLC Cyclophosphamide Product Portfolio Table 90. Amneal Pharmaceuticals LLC Recent Development Table 91. Jiangsu Hengrui Medicine Company Information Table 92. Jiangsu Hengrui Medicine Business Overview Table 93. Jiangsu Hengrui Medicine Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (USD/Person) and Gross Margin (2021-2026) Table 94. Jiangsu Hengrui Medicine Cyclophosphamide Product Portfolio Table 95. Jiangsu Hengrui Medicine Recent Development Table 96. NorthStar Rx LLC Company Information Table 97. NorthStar Rx LLC Business Overview Table 98. NorthStar Rx LLC Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (USD/Person) and Gross Margin (2021-2026) Table 99. NorthStar Rx LLC Cyclophosphamide Product Portfolio Table 100. NorthStar Rx LLC Recent Development Table 101. GLS Pharma Company Information Table 102. GLS Pharma Business Overview Table 103. GLS Pharma Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (USD/Person) and Gross Margin (2021-2026) Table 104. GLS Pharma Cyclophosphamide Product Portfolio Table 105. GLS Pharma Recent Development Table 106. CSC Pharmaceuticals International Company Information Table 107. CSC Pharmaceuticals International Business Overview Table 108. CSC Pharmaceuticals International Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (USD/Person) and Gross Margin (2021-2026) Table 109. CSC Pharmaceuticals International Cyclophosphamide Product Portfolio Table 110. CSC Pharmaceuticals International Recent Development Table 111. North America Cyclophosphamide Market Size Growth Rate (CAGR) by Country (Person): 2021 VS 2025 VS 2032 Table 112. North America Cyclophosphamide Sales by Country (2021-2026) & (Person) Table 113. North America Cyclophosphamide Sales Market Share by Country (2021-2026) Table 114. North America Cyclophosphamide Sales Forecast by Country (2027-2032) & (Person) Table 115. North America Cyclophosphamide Sales Market Share Forecast by Country (2027-2032) Table 116. North America Cyclophosphamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Cyclophosphamide Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Cyclophosphamide Market Share by Country (2021-2026) Table 119. North America Cyclophosphamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Cyclophosphamide Market Share Forecast by Country (2027-2032) Table 121. Europe Cyclophosphamide Market Size Growth Rate (CAGR) by Country (Person): 2021 VS 2025 VS 2032 Table 122. Europe Cyclophosphamide Sales by Country (2021-2026) & (Person) Table 123. Europe Cyclophosphamide Sales Market Share by Country (2021-2026) Table 124. Europe Cyclophosphamide Sales Forecast by Country (2027-2032) & (Person) Table 125. Europe Cyclophosphamide Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Cyclophosphamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Cyclophosphamide Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Cyclophosphamide Market Share by Country (2021-2026) Table 129. Europe Cyclophosphamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Cyclophosphamide Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Cyclophosphamide Market Size Growth Rate (CAGR) by Country (Person): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Cyclophosphamide Sales by Country (2021-2026) & (Person) Table 133. Asia-Pacific Cyclophosphamide Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Cyclophosphamide Sales Forecast by Country (2027-2032) & (Person) Table 135. Asia-Pacific Cyclophosphamide Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Cyclophosphamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Cyclophosphamide Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Cyclophosphamide Market Share by Country (2021-2026) Table 139. Asia-Pacific Cyclophosphamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Cyclophosphamide Market Share Forecast by Country (2027-2032) Table 141. Latin America Cyclophosphamide Market Size Growth Rate (CAGR) by Country (Person): 2021 VS 2025 VS 2032 Table 142. Latin America Cyclophosphamide Sales by Country (2021-2026) & (Person) Table 143. Latin America Cyclophosphamide Sales Market Share by Country (2021-2026) Table 144. Latin America Cyclophosphamide Sales Forecast by Country (2027-2032) & (Person) Table 145. Latin America Cyclophosphamide Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Cyclophosphamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Cyclophosphamide Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Cyclophosphamide Market Share by Country (2021-2026) Table 149. Latin America Cyclophosphamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Cyclophosphamide Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Cyclophosphamide Market Size Growth Rate (CAGR) by Country (Person): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Cyclophosphamide Sales by Country (2021-2026) & (Person) Table 153. Middle East and Africa Cyclophosphamide Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Cyclophosphamide Sales Forecast by Country (2027-2032) & (Person) Table 155. Middle East and Africa Cyclophosphamide Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Cyclophosphamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Cyclophosphamide Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Cyclophosphamide Market Share by Country (2021-2026) Table 159. Middle East and Africa Cyclophosphamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Cyclophosphamide Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Cyclophosphamide Distributors List Table 164. Cyclophosphamide Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Cyclophosphamide Image Figure 2. Global Cyclophosphamide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyclophosphamide Market Size (2021-2032) & (US$ Million) Figure 4. Global Cyclophosphamide Sales (2021-2032) & (Person) Figure 5. High-Dose Image Figure 6. Global High-Dose Sales YoY Growth (2021-2032) & (Person) Figure 7. Low-Dose Image Figure 8. Global Low-Dose Sales YoY Growth (2021-2032) & (Person) Figure 9. Global Cyclophosphamide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cyclophosphamide Market Share by Type 2025 VS 2032 Figure 11. North America Cyclophosphamide Sales Market Share in Volume by Type in 2025 Figure 12. North America Cyclophosphamide Sales Market Share in Value by Type in 2025 Figure 13. Europe Cyclophosphamide Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cyclophosphamide Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cyclophosphamide Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cyclophosphamide Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cyclophosphamide Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cyclophosphamide Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cyclophosphamide Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cyclophosphamide Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cyclophosphamide Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cancer Image Figure 24. Global Cancer Sales YoY Growth (2021-2032) & (Person) Figure 25. Autoimmune Diseases Image Figure 26. Global Autoimmune Diseases Sales YoY Growth (2021-2032) & (Person) Figure 27. AL Amyloidosis Image Figure 28. Global AL Amyloidosis Sales YoY Growth (2021-2032) & (Person) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Person) Figure 31. Global Cyclophosphamide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cyclophosphamide Market Share by Application 2025 VS 2032 Figure 33. North America Cyclophosphamide Sales Market Share in Volume by Application in 2025 Figure 34. North America Cyclophosphamide Sales Market Share in Value by Application in 2025 Figure 35. Europe Cyclophosphamide Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cyclophosphamide Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cyclophosphamide Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cyclophosphamide Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cyclophosphamide Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cyclophosphamide Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cyclophosphamide Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cyclophosphamide Sales Market Share in Value by Application in 2025 Figure 43. North America Cyclophosphamide Sales by Country: 2021 VS 2025 VS 2032 (Person) Figure 44. North America Cyclophosphamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cyclophosphamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cyclophosphamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cyclophosphamide Sales by Country: 2021 VS 2025 VS 2032 (Person) Figure 48. Europe Cyclophosphamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cyclophosphamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cyclophosphamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cyclophosphamide Sales by Country: 2021 VS 2025 VS 2032 (Person) Figure 52. Asia-Pacific Cyclophosphamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cyclophosphamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cyclophosphamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cyclophosphamide Sales by Country: 2021 VS 2025 VS 2032 (Person) Figure 56. Latin America Cyclophosphamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cyclophosphamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cyclophosphamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cyclophosphamide Sales by Country: 2021 VS 2025 VS 2032 (Person) Figure 60. Middle East and Africa Cyclophosphamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cyclophosphamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cyclophosphamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cyclophosphamide Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cyclophosphamide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • High-Dose
  • Low-Dose
Applications
  • Cancer
  • Autoimmune Diseases
  • AL Amyloidosis
  • Others
Companies covered
  • Baxter
  • Novartis
  • Hikma Pharmaceuticals
  • Amneal Pharmaceuticals LLC
  • Jiangsu Hengrui Medicine
  • NorthStar Rx LLC
  • GLS Pharma
  • CSC Pharmaceuticals International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cyclophosphamide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cyclophosphamide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cyclophosphamide Market by Type
  6. 1.3.1 High-Dose
  7. 1.3.2 Low-Dose
  8. 1.4 Global Cyclophosphamide Market Size by Type
  9. 1.4.1 Global Cyclophosphamide Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cyclophosphamide Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cyclophosphamide Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cyclophosphamide Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cyclophosphamide Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cyclophosphamide Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cyclophosphamide Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cyclophosphamide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cyclophosphamide Industry Trends
  2. 2.2 Cyclophosphamide Industry Drivers
  3. 2.3 Cyclophosphamide Industry Opportunities and Challenges
  4. 2.4 Cyclophosphamide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cyclophosphamide Revenue (2021-2026)
  2. 3.2 Global Top Players by Cyclophosphamide Sales (2021-2026)
  3. 3.3 Global Top Players by Cyclophosphamide Price (2021-2026)
  4. 3.4 Global Cyclophosphamide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cyclophosphamide Major Company Production Sites & Headquarters
  6. 3.6 Global Cyclophosphamide Company, Product Type & Application
  7. 3.7 Global Cyclophosphamide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cyclophosphamide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cyclophosphamide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cyclophosphamide Tier 1, Tier 2, and Tier 3
4 Cyclophosphamide Regional Status and Outlook
  1. 4.1 Global Cyclophosphamide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cyclophosphamide Historic Market Size by Region
  3. 4.2.1 Global Cyclophosphamide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cyclophosphamide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cyclophosphamide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cyclophosphamide Forecasted Market Size by Region
  7. 4.3.1 Global Cyclophosphamide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cyclophosphamide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cyclophosphamide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cyclophosphamide by Application
  1. 5.1 Cyclophosphamide Market by Application
  2. 5.1.1 Cancer
  3. 5.1.2 Autoimmune Diseases
  4. 5.1.3 AL Amyloidosis
  5. 5.1.4 Others
  6. 5.2 Global Cyclophosphamide Market Size by Application
  7. 5.2.1 Global Cyclophosphamide Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Cyclophosphamide Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Cyclophosphamide Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Cyclophosphamide Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Cyclophosphamide Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Cyclophosphamide Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Cyclophosphamide Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Cyclophosphamide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Baxter
  2. 6.1.1 Baxter Company Information
  3. 6.1.2 Baxter Business Overview
  4. 6.1.3 Baxter Cyclophosphamide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Baxter Cyclophosphamide Product Portfolio
  6. 6.1.5 Baxter Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Cyclophosphamide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Cyclophosphamide Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Hikma Pharmaceuticals
  14. 6.3.1 Hikma Pharmaceuticals Company Information
  15. 6.3.2 Hikma Pharmaceuticals Business Overview
  16. 6.3.3 Hikma Pharmaceuticals Cyclophosphamide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hikma Pharmaceuticals Cyclophosphamide Product Portfolio
  18. 6.3.5 Hikma Pharmaceuticals Recent Developments
  19. 6.4 Amneal Pharmaceuticals LLC
  20. 6.4.1 Amneal Pharmaceuticals LLC Company Information
  21. 6.4.2 Amneal Pharmaceuticals LLC Business Overview
  22. 6.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Amneal Pharmaceuticals LLC Cyclophosphamide Product Portfolio
  24. 6.4.5 Amneal Pharmaceuticals LLC Recent Developments
  25. 6.5 Jiangsu Hengrui Medicine
  26. 6.5.1 Jiangsu Hengrui Medicine Company Information
  27. 6.5.2 Jiangsu Hengrui Medicine Business Overview
  28. 6.5.3 Jiangsu Hengrui Medicine Cyclophosphamide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jiangsu Hengrui Medicine Cyclophosphamide Product Portfolio
  30. 6.5.5 Jiangsu Hengrui Medicine Recent Developments
  31. 6.6 NorthStar Rx LLC
  32. 6.6.1 NorthStar Rx LLC Company Information
  33. 6.6.2 NorthStar Rx LLC Business Overview
  34. 6.6.3 NorthStar Rx LLC Cyclophosphamide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 NorthStar Rx LLC Cyclophosphamide Product Portfolio
  36. 6.6.5 NorthStar Rx LLC Recent Developments
  37. 6.7 GLS Pharma
  38. 6.7.1 GLS Pharma Company Information
  39. 6.7.2 GLS Pharma Business Overview
  40. 6.7.3 GLS Pharma Cyclophosphamide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GLS Pharma Cyclophosphamide Product Portfolio
  42. 6.7.5 GLS Pharma Recent Developments
  43. 6.8 CSC Pharmaceuticals International
  44. 6.8.1 CSC Pharmaceuticals International Company Information
  45. 6.8.2 CSC Pharmaceuticals International Business Overview
  46. 6.8.3 CSC Pharmaceuticals International Cyclophosphamide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CSC Pharmaceuticals International Cyclophosphamide Product Portfolio
  48. 6.8.5 CSC Pharmaceuticals International Recent Developments
7 North America by Country
  1. 7.1 North America Cyclophosphamide Sales by Country
  2. 7.1.1 North America Cyclophosphamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cyclophosphamide Sales by Country (2021-2026)
  4. 7.1.3 North America Cyclophosphamide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cyclophosphamide Market Size by Country
  6. 7.2.1 North America Cyclophosphamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cyclophosphamide Market Size by Country (2021-2026)
  8. 7.2.3 North America Cyclophosphamide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cyclophosphamide Sales by Country
  2. 8.1.1 Europe Cyclophosphamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cyclophosphamide Sales by Country (2021-2026)
  4. 8.1.3 Europe Cyclophosphamide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cyclophosphamide Market Size by Country
  6. 8.2.1 Europe Cyclophosphamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cyclophosphamide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cyclophosphamide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cyclophosphamide Sales by Country
  2. 9.1.1 Asia-Pacific Cyclophosphamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cyclophosphamide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cyclophosphamide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cyclophosphamide Market Size by Country
  6. 9.2.1 Asia-Pacific Cyclophosphamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cyclophosphamide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cyclophosphamide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cyclophosphamide Sales by Country
  2. 10.1.1 South America Cyclophosphamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cyclophosphamide Sales by Country (2021-2026)
  4. 10.1.3 South America Cyclophosphamide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cyclophosphamide Market Size by Country
  6. 10.2.1 South America Cyclophosphamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cyclophosphamide Market Size by Country (2021-2026)
  8. 10.2.3 South America Cyclophosphamide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cyclophosphamide Sales by Country
  2. 11.1.1 Middle East and Africa Cyclophosphamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cyclophosphamide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cyclophosphamide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cyclophosphamide Market Size by Country
  6. 11.2.1 Middle East and Africa Cyclophosphamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cyclophosphamide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cyclophosphamide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cyclophosphamide Value Chain Analysis
  2. 12.1.1 Cyclophosphamide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cyclophosphamide Production Mode & Process
  7. 12.2 Cyclophosphamide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cyclophosphamide Distributors
  10. 12.2.3 Cyclophosphamide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst